Jonathan Friedlander

Principal

Jonathan is a Principal at Digitalis Ventures.

He received his PhD in cell biology from the University of Cambridge and an MBA from Harvard Business School. Prior to Digitalis, Jonathan was an associate at Flagship Pioneering where he worked on the creation of biotech companies for human therapeutics and agriculture.

LinkedIn

Twitter

COMPANIES

Alcea Therapeutics

Base5 Genomics

GRO Biosciences

Girihlet
Matchpoint Therapeutics